The novel treatment of the medication represents a significant advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide658339.blazingblog.com/42046087/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment